16-hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.02,7.09,18.012,17]nonadeca-1,3,7,9(18)-tetraen-5-one
-
![16-hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.02,7.09,18.012,17]nonadeca-1,3,7,9(18)-tetraen-5-one structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/c161c68a0ab04b56b01b46fdc3fe6b1c.png "16-hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.02,7.09,18.012,17]nonadeca-1,3,7,9(18)-tetraen-5-one")
16-hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.02,7.09,18.012,17]nonadeca-1,3,7,9(18)-tetraen-5-one
structure -
-
CAS No:
33044-74-5
-
Formula:
C19H20O5
-
Chemical Name:
16-hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.02,7.09,18.012,17]nonadeca-1,3,7,9(18)-tetraen-5-one
-
Synonyms:
16-Hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo(13.3.1.02,7.09,18.012,17)nonadeca-1,3,7,9(18)-tetraen-5-one;2,12-Epoxy-2H,9H-benzo(d)benzo(1,2-b:5,4-b')dipyran-9-one, 1,3,4,4a,5,12b-hexahydro-1-hydroxy-2,5,5-trimethyl-;bruceol;Bruceol;(-)-Bruceol;MLS002694163;33044-74-5;NSC83433;NCIOpen2_009184;DTXSID90954664;NSC-83433;SMR001560092;1-Hydroxy-2,5,5-trimethyl-1,3,4,4a,5,12b-hexahydro-2H,9H-2,12-epoxybenzo[d]benzo[1,2-b:5,4-b']dipyran-9-one;2,9H-dipyrano[4,3,2-de:3',2'-g][1]benzopyran-9-one, 3,3a,4,5-tetrahydro-3-hydroxy-2,5,5-trimethyl-, [2R-(2.alpha.,3.beta.,3a.beta.,4.alpha.)]-
-
CAS No:
16-hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo[13.3.1.02,7.09,18.012,17]nonadeca-1,3,7,9(18)-tetraen-5-one Basic Attributes
328.4 g/mol
328.13107373 g/mol
83433
Drug Information
16-Hydroxy-11,11,15-trimethyl-6,10,19-trioxapentacyclo(13.3.1.02,7.09,18.012,17)nonadeca-1,3,7,9(18)-tetraen-5-one
Computed Properties
Molecular Weight:328.4
XLogP3:2.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Exact Mass:328.13107373
Monoisotopic Mass:328.13107373
Topological Polar Surface Area:65
Heavy Atom Count:24
Complexity:613
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation